Docs in Japan have found that “nose-brain direct transport” beats injection for delivering a brain cancer-fighting drug:
Nasal chemotherapy with MTX significantly reduced the tumor weight as compared to nontreatment control and IP group. The strategy to utilize the nose−brain direct transport can be applicable to a new therapeutic system not only for brain tumors but also for other central nervous system disorders such as neurodegenerative diseases.